Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Vivimed Labs

Sector: Healthcare | Industry: Drugs & Pharma
R 13.15 -0.25  | -1.87% -66.88% 2.80 109.86
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 13.15 -0.25 -1.87% 13.75 13.40 48,163 13.00 - 13.75
BSE Oct 15, 2019 13.25 0.00 0.00% 13.55 13.25 24,928 12.65 - 13.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 170,721 P/B: 0.19 NSE Code: VIVIMEDLAB
52-Week Range: R 12.60 - 43.80 Dividend Yield: 0.00% BSE Code: 532660
TTM EPS: R 4.74 Book Value: R 71.25 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Vivimed Labs -64.04 -24.93 -14.52 -66.62 -51.19 -29.70 -6.57
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.92 -0.76 -0.53
Net Profit -24.61 -11.82 -2.88
EPS -26.40 -12.36 -3.24
Book Value -32.74 3.10 3.81
Average
Operating Margin 15.43 20.86 19.51
Net Margin 4.25 8.37 7.28
Return on Networth 7.95 17.63 16.86
Return on Investment 7.03 12.64 12.15
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -1.11 -4.00 -1.11
Operating Profit 54.13 -43.17 54.13
Net Profit 72,385.71 -64.34 72,385.71
EPS 71,894.12 -64.51 71,894.12
TTM
Revenue -1.09 6.08 -1.09
Operating Profit -16.07 -25.73 -16.07
Net Profit -31.79 -51.11 -31.79
EPS -31.87 -52.36 -31.87
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Vivimed Labs 109.86 1,300.84 39.28 2.98 7.95 0.19 2.80
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 01, 2018 BBR Projects Pvt Ltd  Buy Inter-Se Transfer 500,000 61.85 309.25
Jun 01, 2018 Manohar Rao Varalwar  Sell Inter-Se Transfer 500,000 61.85 309.25
Mar 21, 2018 BBR Projects Pvt Ltd  Buy Market 100,000 76.25 76.25
Mar 13, 2018 BBR Projects Pvt Ltd  Buy Market 200,000 77.20 154.40
Mar 12, 2018 BBR Projects Pvt Ltd  Buy Market 144,835 75.55 109.42
Fund Houses invested in the stock
Fund Dec-16 Sep-16 Jun-16 Mar-16 Dec-15
Edelweiss Mutual Fund 0.294 0.294 0.196 0.196 0.170
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Vivimed Labs Ltd.

Address: Plot No 78 - A, Kolar Industrial Area, Bidar, Karnataka - 585403 | Phone: 08482-232045 | Fax: 08482-232436

Email: [email protected]/[email protected]

Website: www.vivimedlabs.com

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285 , Domalaguda,,Hyderabad, 1-2-285, Domalaguda | Phone: 040-7642217/7634445 | Fax: 040-7632184

Essential checks
Altman Z-Score
1.29
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
2.80
5-Years Price to Book
0.19
Earnings Yield
EBIT / Enterprise value
10.35%
PEG
Price / Earnings to growth ratio
-0.31
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59